The U266 MM cell line was treated with the demethylating agent decitabine (DAC) to evaluate its effects on RASD1 expression and apoptosis.<h4>Results</h4>RASD1 mRNA and protein expression were significantly downregulated in patients with MM compared to healthy controls (P < 0.001). The gene discussed is RASD1; the disease is Miyoshi myopathy.